Surgical Treatment of Gastric Gastrointestinal Stromal Tumors: Analysis of 92 Operated Patients
- 23 June 2008
- journal article
- research article
- Published by S. Karger AG in Digestive Surgery
- Vol. 25 (3) , 208-212
Abstract
Aim: To review and evaluate the clinicopathological factors predictive of recurrence after surgical resection for gastrointestinal stromal tumor (GIST) of the stomach. Methods: The clinicopathological records of 92 gastric GIST patients who were operated upon at a single institute from 1996 to 2005 were retrospectively reviewed and assessed for recurrence-free survival. Results: The patients included 43 men and 49 women. Their ages ranged from 25 to 91 years. The size of the tumors varied from 0.8 to 47.7 cm (median 5.8; 95% CI 6.4–9.2 cm). All but one operative margin were clear. The follow-up period ranged from 11 to 112 months (median 31, 95% CI 33.7–43.5 months). Fifteen patients (16%) developed disease recurrence, of which liver metastasis was the most common. Only 1 of the patients with tumors <4 cm developed recurrence. The 3-year recurrence-free survival rates for patients with tumors smaller or larger than 4 cm were 93 and 56.0%, respectively (p < 0.01). Multivariate analysis showed that the tumor size was the independent factor that was inversely associated with recurrence-free survival. Conclusion: The tumor size is an important prognostic factor for recurrence after surgery. Early excision is recommended for gastric GISTs even of small size.Keywords
This publication has 23 references indexed in Scilit:
- Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated casesSurgery, 2006
- Gastrointestinal Stromal Tumors of the StomachAmerican Journal of Surgical Pathology, 2005
- Laparoscopic resection of gastrointestinal mesenchymal tumors located in the upper stomachSurgical Endoscopy, 2004
- Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patientsGastric Cancer, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in SizeThe American Journal of Pathology, 2002
- Gastrointestinal Stromal TumorsCancer Control, 2001
- Prognosis of Gastrointestinal Smooth-Muscle (Stromal) TumorsAmerican Journal of Surgical Pathology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomasCancer, 1992